Inactive Instrument

Highlights Amarillo Biosciences, Inc. Other OTC

Equities

AMAR

US02301P2056

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Ainos to Start Clinical Trial of Potential Animal Drug for Oral Disease Treatment	15/05	MT
Ainos, Inc. to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's Potential Market	15/05	CI
Earnings Flash (AIMD) AINOS Reports Q1 Revenue $20,729	14/05	MT
Ainos, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
Ainos, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	09/03	CI
Ainos Submits Clinical Hold Complete Response to US FDA to Address Issues in Phase 2 Veldona Trial	05/02	MT
Ainos, Inc. Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase Ii Trial of Its Veldona Formulation Against Mild Covid-19 Symptoms	05/02	CI
Ainos, Inc. Enters into Five-Year Product Development Agreement with Taiwan Carbon Nano Technology Corporation	13/01	CI
Ainos Regains Compliance With Nasdaq Listing Rule	02/01	MT
Ainos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-Development Powered by Ai Nose, Accelerating the Digitalization of Smell	26/12	CI
Ainos, Inc. Announces Positive Data Reports from its Clinical Studies for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA	21/11	CI
Earnings Flash (AIMD) AINOS Reports Q3 Revenue $24,489	10/11	MT
Ainos, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11	CI
Ainos, Inc. Signs MoU for Contract Clinical Trials to Conduct Clinical Study of Potential New Animal Drug Based on Veldona	06/11	CI
Ainos, Inc. Commences Shipping its VELDONA Pet Cytoprotein Supplements in Taiwan	05/23/05	CI
Earnings Flash (AIMD) AINOS Reports Q2 Revenue $28,555	12/23/12	MT
Ainos, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	12/23/12	CI
Ainos Partners with Nisshinbo Micro Devices and Inabata to Co-Develop VOC Sensing Platform for Broader Industry Adoption	10/23/10	CI
Ainos to Co-Develop Sensing Platform with Nisshinbo Micro Devices, Inabata Sangyo	09/23/09	MT
Ainos, Inc. Completes VELDONA Pet Line-Up by Launching New VELDONA Pet Shiny and Slim in Push Towards $20 Million Revenue Target	14/23/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Amarillo Biosciences, Inc. Other OTC

Equities

AMAR

US02301P2056

Highlights

Filters